Companies: 10,795·Total market cap: $144.5T
Dynavax Technologies Corporation

Dynavax Technologies Corporation

DVAXNASDAQHealthcare
$15.50
+$0.00(+0.00%)
Market Cap$1.8B
P/E Ratio—
52W High$15.73
52W Low$9.2
SEC Filings

Dynavax Technologies Corporation (DVAX) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001029142 · DVAX · NASDAQ · as of Jun 8, 2026

Filing snapshot

1,000+
Total Filings
15-12G
Latest Form
2026-02-20
Most Recent
2004
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001029142 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2025-02-20
Fiscal Year End
Feb 20, 2025
Accession No.
0001029142-25-000049
Primary Document
dvax-20241231.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001029142 · Accession 0001029142-25-000049

Latest Key Filings

10-QQuarterly Report
10-Q
2025-11-05
View 10-Q on SEC
8-KCurrent Report
8-K
2026-02-10Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
15-12G15-12G
15-12G
2026-02-20
View
EFFECTEFFECT
EFFECT
2026-02-13
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-02-11
View
S-8 POSS-8 POS
S-8 POS
2026-02-10
View
S-8 POSS-8 POS
S-8 POS
2026-02-10
View
S-8 POSS-8 POS
S-8 POS
2026-02-10
View
S-8 POSS-8 POS
S-8 POS
2026-02-10
View
S-8 POSS-8 POS
S-8 POS
2026-02-10
View
S-8 POSS-8 POS
S-8 POS
2026-02-10
View
S-8 POSS-8 POS
S-8 POS
2026-02-10
View
S-8 POSS-8 POS
S-8 POS
2026-02-10
View
S-8 POSS-8 POS
S-8 POS
2026-02-10
View
S-8 POSS-8 POS
S-8 POS
2026-02-10
View
S-8 POSS-8 POS
S-8 POS
2026-02-10
View
S-8 POSS-8 POS
S-8 POS
2026-02-10
View
Showing 1–15 of 557 filingsForm 4 / 144 hidden· 1000 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001029142  |  Exchange: NASDAQ · Healthcare

Dynavax Technologies Corporation (NASDAQ: DVAX) has submitted 1,000+ documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2004. As a Healthcare sector company with CIK 0001029142, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Dynavax Technologies Corporation's most comprehensive regulatory disclosure. The most recent Dynavax Technologies Corporation 10-K was filed on 2025-02-20 for fiscal year ending 2025. Historical DVAX 10-K annual reports are available from 2013 through 2025.

Investors researching Dynavax Technologies Corporation SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Healthcare
ELVN SEC Filings →PLSE SEC Filings →STAA SEC Filings →IMTX SEC Filings →HROW SEC Filings →COLL SEC Filings →EVO SEC Filings →PCRX SEC Filings →
→ DVAX Financials→ DVAX Earnings→ DVAX Insider Trades

Frequently Asked Questions

DVAX SEC Filings · 8 questions

Dynavax Technologies Corporation (DVAX) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 1,000+ filings and access original documents at no cost. Dynavax Technologies Corporation's CIK is 0001029142.

DVAX SEC filingsDynavax Technologies Corporation SEC documentsfind DVAX 10-K